All persons or entities that purchased or otherwise acquired the publicly traded common stock of Applied Therapeutics, Inc., (“Applied”) on a U.S. based exchange between January 3, 2024 and December 2, 2024, inclusive.
Final Approval
January 02, 2024 - December 03, 2024
March 19, 2026
February 26, 2026
Angeion Group
1650 Arch Street, Suite 2210
Philadelphia, PA 19103
+1 833-703-4229
[email protected]
Levi & Korsinsky did not act as lead counsel or otherwise participate in litigating the above class action and provides this information to remind class members of the deadline to submit a claim for a share of any of the settlement fund.